Showing 4,801 - 4,820 results of 19,958 for search '(( 50 ((ms decrease) OR (nn decrease)) ) OR ( 100 ((a decrease) OR (we decrease)) ))', query time: 0.71s Refine Results
  1. 4801
  2. 4802
  3. 4803

    Species richness (<i>SR</i>, upper panels) and Shannon’s entropy (<i>SE</i>, lower panels) vs. the rate in which new species are trying to invade the community, <i>νN</i>. by Immanuel Meyer (12306666)

    Published 2022
    “…However, as the number of temporal niches decreases global competition puts a hurdle against invasion, as every invader must compete with niche-specialists. …”
  4. 4804

    Prolonged exposure to oxytocin enhances neuronal but impairs astrocytic and oligodendrocytic differentiation. by Arvind Palanisamy (3159156)

    Published 2018
    “…<p>Bar graphs showing the proportion of neurons (Neu N), astrocytes (GFAP), oligodendrocytes (Olig2), and nestin<sup>+</sup> NPCs, two weeks after treatment with 100 nM oxytocin for 24 h followed by mitogen withdrawal. …”
  5. 4805

    Synthesis of Triazole Schiff’s Base Derivatives and Their Inhibitory Kinetics on Tyrosinase Activity by Feng Yu (273443)

    Published 2015
    “…Compounds Y<sub>1</sub>, Y<sub>2</sub> and Y<sub>3</sub> showed potent inhibitory effects with respective IC<sub>50</sub> value of 12.5, 7.0 and 1.5 μM on the diphenolase activities. …”
  6. 4806
  7. 4807
  8. 4808
  9. 4809

    Table_1_Respiratory Mucosal Immunity: Kinetics of Secretory Immunoglobulin A in Sputum and Throat Swabs From COVID-19 Patients and Vaccine Recipients.DOCX by Cuiping Ren (336161)

    Published 2022
    “…<p>While IgM and IgG response to SARS-CoV-2 has been extensively studied, relatively little is known about secretory IgA (sIgA) response in respiratory mucosa. Here we report IgA response to the SARS-CoV-2 in sputum, throat swabs, and serum with nucleocapsid protein (NP) enzyme-linked immunosorbent assays (ELISA) in a cohort of 28 COVID-19 patients and 55 vaccine recipients. …”
  10. 4810
  11. 4811

    S1 Data - by Eunae Byun (9925491)

    Published 2024
    “…<div><p>Introduction</p><p>Although extracorporeal membrane oxygenation (ECMO) is a well-established treatment for supporting severe cardiopulmonary failure, the morbidity and mortality of patients requiring ECMO support remain high. …”
  12. 4812
  13. 4813

    Effect of trabectedin on the spheroids in CD133<sup>high</sup>/CD44<sup>high</sup> DU-145 and PC-3 CSCs. by Eda Acikgoz (816259)

    Published 2015
    “…After the beginning of the multicellular tumor spheroid formation, trabectedin was added at various concentrations of trabectedin (0.1, 1, 10, 100 nM) for 24, 48 and 72 h. A significant decrease was observed in the diameter of spheroid formation. …”
  14. 4814
  15. 4815

    Trends in Glucose Lowering Drug Utilization, Glycemic Control, and Severe Hypoglycemia in Adults with Diabetes in Hong Kong 2002-2016 by Aimin Yang (393426)

    Published 2020
    “…The proportion of patients with HbA1c of 6.0-7.0% (42-to-53 mmol/mol) increased from 28.6% to 43.4% while SH rate declined from 4.2 per 100-person-years to 1.3 per 100-person-years. …”
  16. 4816
  17. 4817

    Assay for the optimal temperature of PhaZ<sub>UD</sub>. by Tomohiro Morohoshi (5735813)

    Published 2020
    “…After incubation for 1 h, PHBH-degrading activity was evaluated by measuring the decrease in turbidity at 600 nm. The maximum activity of each PHBH degradation was defined as 100%. …”
  18. 4818
  19. 4819
  20. 4820

    Effects of AngII and ACE2 on oxidative stress in Neuro2A cells. by Huijing Xia (258320)

    Published 2013
    “…<p>Western blots showed that AngII treatment (100 nmol/L, 24 h) decreased ACE2 (A; 100 KDa, n = 6, **<i>P</i><0.01 vs. vehicle), increased AT1R (43 KDa; B; n = 6, *<i>P</i><0.05 vs. vehicle) without changing AT2R (44 KDa; C; <i>P</i>>0.05 vs. vehicle) protein expression. …”